TargetMol

Norethindrone

Product Code:
 
TAR-T1514
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1514-50mg50mg£101.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1514-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1514-100mg100mg£113.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1514-200mg200mg£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1514-500mg500mg£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Norethindrone is a synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.
CAS:
68-22-4
Formula:
C20H26O2
Molecular Weight:
298.42
Pathway:
Endocrinology/Hormones;
Purity:
0.9955
SMILES:
[C@@H]12[C@@]([C@@](CC2)(C#C)O)(CC[C@H]2[C@H]1CCC1=CC(=O)CC[C@H]21)C
Target:
Estrogen/progestogen Receptor; Progesterone Receptor

Documents

References

1. Schindler AE, et al. Maturitas, 2003, 46 Suppl 1, S7-S16. 2. Schoonen WG, et al. J Steroid Biochem Mol Biol, 2000, 74(4), 213-222. 3. Seeger H, et al. J Br Menopause Soc, 2003, 9(1), 36-38. 4. Enr?quez J, et al. J Endocrinol. 2007 Jun;193(3):493-504. 5. Bain SD, et al. J Bone Miner Res, 1993, 8(2), 219-230. 6. Zeng X, Zhu S, Lu W, et al. Target identification among known drugs by deep learning from heterogeneous networks[J]. Chemical Science. 2020, 11(7): 1775-1797.